MedTrace Logo

MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease

NCT02917148 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-10-11

No results posted yet for this study

Summary

The goal of this research proposal is to identify a miRNA expression profile as a biomarker to diagnose and predict acute graft versus host disease (aGVHD) in patients who undergo allogeneic transplantation. This biomarker, once identified, will need validation in larger cohorts.

Conditions

  • Acute GVH Disease

Interventions

OTHER

Peripheral Venipuncture or Blood draw from Central Line

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Cheryl Mensah, MD · Northwell Health

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917148 on ClinicalTrials.gov